Welcome to our dedicated page for Astrana Health news (Ticker: AMEH), a resource for investors and traders seeking the latest updates and insights on Astrana Health stock.
Astrana Health, Inc. (NASDAQ: AMEH), formerly known as Apollo Medical Holdings, Inc., is a leading physician-centric, technology-powered healthcare management company. Based in Alhambra, California, the company leverages proprietary population health management and healthcare delivery platforms to operate an integrated, value-based healthcare model. Astrana Health's mission is to empower medical providers in its network to deliver high-quality, cost-effective care.
The company's extensive network includes primary care physicians, specialists, and hospitalists, catering to patients covered by various insurance plans including Medicare, Medicaid, and private insurance. Astrana Health's services encompass care coordination for patients, families, primary care physicians, specialists, acute care hospitals, and physician groups.
Key Highlights and Achievements:
- Strong Financial Performance: In 2023, Astrana Health reported a significant increase in revenue and net income. For example, total revenue for the second quarter of 2023 was $348.2 million, up 29% from the previous year.
- Strategic Acquisitions and Partnerships: The company has expanded its reach through strategic acquisitions and partnerships. Recent deals include acquiring assets from Texas Independent Providers, forming partnerships with primary care groups in California, and collaborating with IntraCare.
- Environmental, Social, and Governance (ESG) Initiatives: Astrana Health released its inaugural ESG At-a-Glance Report in 2023, highlighting achievements in health equity, community engagement, and environmental responsibility.
- Technological Advancements: The company continues to invest in technology to enhance its healthcare delivery platform, enabling providers to participate in value-based care arrangements and improve patient outcomes.
Ongoing Projects:
- Value-Based Care: Astrana Health remains committed to expanding its value-based care model, focusing on improving patient outcomes and reducing healthcare costs.
- Expansion of Services: The company plans to broaden its healthcare services across multiple states, including California, Nevada, Texas, and beyond.
- Provider Empowerment: Astrana Health continues to focus on empowering its network of providers through training and technology, ensuring they can deliver the best possible care.
For more information, visit www.apollomed.net.
Apollo Medical Holdings, Inc. (NASDAQ: AMEH) announced on November 17, 2022, its certification from the National Committee for Quality Assurance (NCQA) for the Healthcare Effectiveness Data and Information Set (HEDIS) for the measurement year 2022. This certification enables ApolloMed to enhance the delivery of value-based care through its newly developed HEDIS engine, which improves the identification of care gaps and aligns with rigorous clinical quality standards. Key measures certified include diabetes control and child well-care visits, supporting ApolloMed's mission in integrated healthcare delivery.
Apollo Medical Holdings, Inc. (NASDAQ: AMEH) reported a 40% revenue increase to $317.0 million for Q3 2022, but net income decreased to $26.0 million from $34.3 million year-over-year. For the nine months ending September 30, 2022, total revenue was $850.0 million, up 47%, yet net income fell to $51.6 million from $60.1 million. The company is raising its full-year 2022 guidance for revenue and net income due to growth and favorable membership mix. Recent acquisitions are expected to enhance membership significantly.
Apollo Medical Holdings, Inc. (NASDAQ: AMEH) will release its financial results for the third quarter and nine months ending September 30, 2022, on November 3, 2022, after market close. A conference call to discuss these results is scheduled for November 4, 2022, at 5:30 a.m. PT/8:30 a.m. ET. Investors can access the call via dial-in or online webcast, with a slide presentation available on the Company’s website. ApolloMed is focused on value-based care through its technology-powered healthcare model, enabling providers to deliver efficient patient care.
Apollo Medical Holdings, Inc. (NASDAQ: AMEH) announced an agreement to acquire Valley Oaks Medical Group, encompassing nine primary care clinics in Las Vegas, Houston, and Fort Worth. This strategic acquisition will expand ApolloMed's operations into Nevada and Texas while enhancing its value-based care services for over 20,000 patients, including 6,000 Medicare members. The transaction, expected to close by Q4 2022, will be funded with cash on hand. Leaders from both companies expressed enthusiasm for the partnership, aiming to improve healthcare delivery in underserved communities.
Apollo Medical Holdings, Inc. (NASDAQ: AMEH) announced a definitive agreement to acquire All American Medical Group (AAMG) and For Your Benefit, Inc. (FYB) to enhance its value-based care services. This acquisition includes 100% of AAMG's and FYB's assets and is expected to close by Q1 2023, pending regulatory approval. The deal will integrate over 15,000 patients in the San Francisco area into ApolloMed's network, expanding its reach to over 30,000 members in Northern California and leveraging AAMG's community-focused services.
Apollo Medical Holdings, Inc. (NASDAQ: AMEH) announced its participation in two virtual investor conferences. The Bank of America Healthcare Innovation Forum is scheduled for September 29, 2022, followed by the Barclays Value Based Care Investor Conference on October 6, 2022. Management will engage in one-on-one meetings at both events. ApolloMed, a technology-powered healthcare management firm, specializes in value-based care, providing integrated platforms to enhance patient care. For further information, visit www.apollomed.net.
Apollo Medical Holdings, Inc. reported significant financial results for Q2 and the first half of 2022. Total revenue reached $269.7 million, up 54% year-over-year. However, net income slightly decreased to $11.4 million from $12.7 million in Q2 2021. Year-to-date revenue rose 52% to $533.0 million, with net income nearly unchanged at $25.7 million. The company maintains its full-year guidance, projecting revenue between $1,055.0 million and $1,085.0 million. Cash reserves stood at $234.2 million as of June 30, 2022.
Apollo Medical Holdings, Inc. (NASDAQ: AMEH) will release its financial results for the second quarter and first half of 2022 after the market close on August 4, 2022. A conference call to discuss the results will follow at 2 p.m. PT / 5 p.m. ET. ApolloMed is a technology-powered healthcare management company focused on value-based care, operating an integrated healthcare delivery platform to enhance quality and cost-effective care. The company is headquartered in Alhambra, California.
Apollo Medical Holdings, Inc. (NASDAQ: AMEH) announced that Co-CEO Brandon Sim will present at two key investor conferences in New York. The 2022 RBC Capital Markets Global Healthcare Conference is scheduled for May 18, 2022, at 11:35 a.m. PT. The UBS Global Healthcare Conference 2022 will take place on May 23, 2022, at 11 a.m. PT. Both presentations will be available via live webcast on the company’s website. ApolloMed focuses on value-based care and operates an integrated healthcare delivery platform.
Apollo Medical Holdings, Inc. (NASDAQ: AMEH) has appointed Chan Basho as Chief Strategy Officer and Interim Chief Financial Officer, following Eric Chin's departure for personal reasons. Basho, with 15 years of experience in healthcare strategy and finance, is expected to enhance the company's growth strategy and ensure operational discipline. The leadership transition aims to strengthen ApolloMed's mission to deliver cost-effective, high-quality healthcare. Chin will remain with the company as an executive advisor for a smooth transition.
FAQ
What is the market cap of Astrana Health (AMEH)?
What does Astrana Health, Inc. do?
Where is Astrana Health, Inc. headquartered?
What type of healthcare model does Astrana Health, Inc. operate?
What recent achievements has Astrana Health, Inc. made?
Who does Astrana Health, Inc. cater to?
What are some of Astrana Health, Inc.'s ongoing projects?
What is the significance of the company's recent rebrand to Astrana Health?
How does Astrana Health, Inc. support its network of providers?
What is the focus of Astrana Health, Inc.'s ESG initiatives?
How can I get more information about Astrana Health, Inc.?
